Auspex Pharmaceuticals, Inc. 4
4 · Auspex Pharmaceuticals, Inc. · Filed Jan 30, 2015
Insider Transaction Report
Form 4
Zisson Alex
Director10% Owner
Transactions
- Sale
Common Stock
2015-01-28$53.11/sh−730,000$38,770,300→ 4,835,731 total(indirect: see footnote)
Footnotes (3)
- [F1]The securities were sold to the underwriter by the Reporting Persons in connection with a secondary offering of the Issuer's securities as follows: 719,780 shares by Thomas, McNerney & Partners II, L.P. ("TMP II"), 7,519 shares by TMP Nominee II, LLC ("TMPN II") and 2,701shares by TMP Associates II, L.P. ("TMPA II").
- [F2]Includes 4,768,041 shares held in the name of TMP II; 49,805 shares held in the name of TMPN II; and 17,885 shares held in the name of TMPA II.
- [F3]The securities are held in the name of TMP II, TMPN II and TMPA II. Thomas, McNerney & Partners II, LLC ("TMP II LLC") is the general partner of TMP II and TMPA II. Alex Zisson is a manager of TMP II LLC and has shared voting and dispositive power over the securities held by TMP II and TMPA II, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.